Chimeric Therapeutics LimitedASX: CHM

Notice of initial substantial holder for CHM

· Issued by Chimeric Therapeutics Limited via ASX

Filed with ASX · · 6 pages · English

Release

Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company/registered scheme/notified foreign passport fund name Chimeric Therapeutics Limited ACN/ARSN/APFRN 638 835 828 1. Details of substantial holder (1) Name Magellan Financial Group Ltd (MFG) and each...

Chimeric Therapeutics Limited on 6ix

Earlier from Chimeric Therapeutics

Later from Chimeric Therapeutics

All Chimeric Therapeutics news releases